RPT — BREAKINGVIEWS — China biotech's ingenuity extends to dealmaking
(The author is a Reuters Breakingviews columnist. The opinions expressed are her own.) By Katrina Hamlin HONG KONG, Oct 16 (Reuters Breakingviews) — Long gone are the days when Big Pharma scoffed at the reliability of China's clinical trials. The world's biggest drugmakers are increasingly looking to biotech researcher